BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35094119)

  • 1. Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours.
    Dominique C; Callonnec F; Berghian A; Defta D; Vera P; Modzelewski R; Decazes P
    Eur Radiol; 2022 Jul; 32(7):4834-4844. PubMed ID: 35094119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of contrast-enhanced spectral mammography (CESM) images.
    Perek S; Kiryati N; Zimmerman-Moreno G; Sklair-Levy M; Konen E; Mayer A
    Int J Comput Assist Radiol Surg; 2019 Feb; 14(2):249-257. PubMed ID: 30367322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of suspicious calcification in the diagnosis and surgical treatment of breast lesions using contrast-enhanced spectral mammography].
    Sun XF; Xing W; Yu SN; Sha YY; Pan L; Chen Q
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(1):42-46. PubMed ID: 31914557
    [No Abstract]   [Full Text] [Related]  

  • 4. Develop and Validate a Nomogram Combining Contrast-Enhanced Spectral Mammography Deep Learning with Clinical-Pathological Features to Predict Neoadjuvant Chemotherapy Response in Patients with ER-Positive/HER2-Negative Breast Cancer.
    Xing D; Lv Y; Sun B; Chu T; Bao Q; Zhang H
    Acad Radiol; 2024 Apr; ():. PubMed ID: 38641451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
    Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
    Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Dual-Energy Contrast-Enhanced Spectral Mammography Can Provide Useful Clinical Information About Prognostic Factors in Breast Cancer Patients: A Systematic Review of Literature.
    Vasselli F; Fabi A; Ferranti FR; Barba M; Botti C; Vidiri A; Tommasin S
    Front Oncol; 2022; 12():859838. PubMed ID: 35941874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
    Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
    Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the classification ability of network utilizing fusion technique in contrast-enhanced spectral mammography.
    Song J; Zheng Y; Xu C; Zou Z; Ding G; Huang W
    Med Phys; 2022 Feb; 49(2):966-977. PubMed ID: 34860417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced spectral mammography improves diagnostic accuracy in the symptomatic setting.
    Tennant SL; James JJ; Cornford EJ; Chen Y; Burrell HC; Hamilton LJ; Girio-Fragkoulakis C
    Clin Radiol; 2016 Nov; 71(11):1148-55. PubMed ID: 27296475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
    Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
    Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative prediction of histologic grade in invasive breast cancer by using contrast-enhanced spectral mammography-based radiomics.
    Mao N; Jiao Z; Duan S; Xu C; Xie H
    J Xray Sci Technol; 2021; 29(5):763-772. PubMed ID: 34151880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria.
    Lalji UC; Jeukens CR; Houben I; Nelemans PJ; van Engen RE; van Wylick E; Beets-Tan RG; Wildberger JE; Paulis LE; Lobbes MB
    Eur Radiol; 2015 Oct; 25(10):2813-20. PubMed ID: 25813015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced spectral mammography (CESM) in women presenting with palpable breast findings.
    Sorin V; Faermann R; Yagil Y; Shalmon A; Gotlieb M; Halshtok-Neiman O; Ben-David MA; Sklair-Levy M
    Clin Imaging; 2020 May; 61():99-105. PubMed ID: 32014818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiview multimodal network for breast cancer diagnosis in contrast-enhanced spectral mammography images.
    Song J; Zheng Y; Zakir Ullah M; Wang J; Jiang Y; Xu C; Zou Z; Ding G
    Int J Comput Assist Radiol Surg; 2021 Jun; 16(6):979-988. PubMed ID: 33966155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided diagnosis of contrast-enhanced spectral mammography: A feasibility study.
    Patel BK; Ranjbar S; Wu T; Pockaj BA; Li J; Zhang N; Lobbes M; Zhang B; Mitchell JR
    Eur J Radiol; 2018 Jan; 98():207-213. PubMed ID: 29279165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
    Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer diagnosis from contrast-enhanced mammography using multi-feature fusion neural network.
    Qian N; Jiang W; Guo Y; Zhu J; Qiu J; Yu H; Huang X
    Eur Radiol; 2024 Feb; 34(2):917-927. PubMed ID: 37610440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
    Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
    Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme.
    Lobbes MB; Lalji U; Houwers J; Nijssen EC; Nelemans PJ; van Roozendaal L; Smidt ML; Heuts E; Wildberger JE
    Eur Radiol; 2014 Jul; 24(7):1668-76. PubMed ID: 24696228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.
    Lalji UC; Houben IP; Prevos R; Gommers S; van Goethem M; Vanwetswinkel S; Pijnappel R; Steeman R; Frotscher C; Mok W; Nelemans P; Smidt ML; Beets-Tan RG; Wildberger JE; Lobbes MB
    Eur Radiol; 2016 Dec; 26(12):4371-4379. PubMed ID: 27097789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.